Your browser doesn't support javascript.
loading
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization.
Strydom, Natasha; Gupta, Sneha V; Fox, William S; Via, Laura E; Bang, Hyeeun; Lee, Myungsun; Eum, Seokyong; Shim, TaeSun; Barry, Clifton E; Zimmerman, Matthew; Dartois, Véronique; Savic, Radojka M.
Afiliação
  • Strydom N; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
  • Gupta SV; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
  • Fox WS; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
  • Via LE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, Maryland, United States of America.
  • Bang H; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, Maryland, United States of America.
  • Lee M; International Tuberculosis Research Center, Changwon, Republic of Korea.
  • Eum S; International Tuberculosis Research Center, Changwon, Republic of Korea.
  • Shim T; Asan Medical Center, Seoul, Republic of Korea.
  • Barry CE; Tuberculosis Research Section, Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, Maryland, United States of America.
  • Zimmerman M; Public Health Research Institute and New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, United States of America.
  • Dartois V; Public Health Research Institute and New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey, United States of America.
  • Savic RM; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, United States of America.
PLoS Med ; 16(4): e1002773, 2019 04.
Article em En | MEDLINE | ID: mdl-30939136
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Tuberculose Resistente a Múltiplos Medicamentos / Pulmão / Antituberculosos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Tuberculose Resistente a Múltiplos Medicamentos / Pulmão / Antituberculosos Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos